| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |